Login/Register
  • 中文
  • English

News

GNTbm’s Breast Cancer Drug Kepida Granted National Health Insurance Reimbursement, Effective December 1

GNTbm announced that its domestically developed anti-breast cancer novel drug Kepida, which has been under development in Taiwan for a decade, has been approved for reimbursement by Taiwan’s National Health Insurance, with coverage taking effect on December 1.

Read more
Nov 17, 2025
Foresee Pharmaceuticals Grants Global Exclusive License of MMP-12 to Related Party QPS, with Total Deal Value and Milestones Up to US$584 Million
Nov 17, 2025
DR.WU SKINCARE Posts Q3 EPS of NT$2.47 as Non-Operating Income Rebounds, Returning to Profitability for the Quarter
Nov 17, 2025
OBI Pharma’s New Drug Granted Orphan Drug Designation in the U.S.
Nov 17, 2025
Biotech Stocks Post First-Three-Quarter Earnings; Top 10 Rankings See Major Shake-Up, with This Stock Retaining EPS Crown at NT$21.34
Nov 14, 2025
Bora Pharmaceuticals Reports Q3 EPS of NT$5.09; Board Approves Share Buyback
Nov 14, 2025
CDIB Capital Group’s Biotech Fund CEO Wu Hsin-Fang: Strategic Alliances Key to Seizing Opportunities
Nov 14, 2025
TCI Launches Biotech 2.0 Plan with Asset-Light, Distributed Strategy
Nov 14, 2025
Global Pharmaceutical Supply Chain Reshaped: Adimmune Chairman Highlights Industry Resilience and Accelerates International GMP Capacity Expansion
Nov 13, 2025
DARWIN PRECISIONS and AUO Partner with Tungs' Taichung Metroharbor Hospital to Launch a New Era of Smart Elderly Rehabilitation

Most Watched

Recommended

Dashboard
BenQ Group
Automatic medicine supply system
Raden Automatic Ltd.
Clinical Grade iPSC Banking
Allele Cypert Technology Inc.

Industry Watch

Read more